ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $147,000 | +0.7% | 44,560 | -7.6% | 0.01% | -12.5% |
| Q1 2019 | $146,000 | +9.0% | 48,207 | -2.0% | 0.01% | -11.1% |
| Q4 2018 | $134,000 | -58.5% | 49,186 | -51.0% | 0.01% | -71.0% |
| Q2 2017 | $323,000 | +2836.4% | 100,330 | +2408.2% | 0.03% | +3000.0% |
| Q1 2017 | $11,000 | -94.3% | 4,000 | -91.6% | 0.00% | -96.8% |
| Q3 2013 | $194,000 | – | 47,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WILLIAM HARRIS INVESTORS INC | 2,338,735 | $6,244,000 | 1.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,603,703 | $25,642,000 | 1.03% |
| Broadfin Capital, LLC | 6,100,000 | $16,288,000 | 0.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,088,675 | $2,907,000 | 0.58% |
| MARINER INVESTMENT GROUP LLC | 296,477 | $792,000 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 36,500 | $97,000 | 0.14% |
| Peregrine Asset Advisers, Inc. | 53,034 | $142,000 | 0.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,165,738 | $3,101,000 | 0.12% |
| Avenir Corp | 341,035 | $911,000 | 0.08% |
| Brown Advisory Securities, LLC | 50,550 | $135,000 | 0.05% |